DURALOC 1599-23-058Recalls & reported problems

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10603295065678), received between Dec 13, 2022 and May 20, 2024 — classified as 3 injuries.

The most frequently reported specific device problem is “Naturally Worn” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

• InjuryMay 20, 2024Naturally Worn; Naturally Worn

  ADDITIONAL INFORMATION RECEIVED: A. CAN YOU PLEASE CLARIFY WHAT BONE INJURY WAS PRESENT? ARTHRO-SYNOVIAL CYSTS RELATED TO PE WEAR. OPPOSITE THE GREATER TROCHANTER AND ON THE ANTERIOR SURFACE OF THE HIP LESS SIGNIFICANTLY BELOW THE INGUINAL LINE.

  Patient problems: Cyst(s); Unspecified Tissue Injury

  MAUDE report 19351925 ↗
• InjuryFeb 6, 2024Naturally Worn; Naturally Worn

  SURGEON IS ORDERING A PATIENT SPECIFIC HIP-INLAY FOR A PLANNED REVISION BECAUSE OF NORMAL AND EXPECTED PE-WEAR LEFT SIDE. THERE HAS BEEN NO ALLEGATION OF ANY PRODUCT DEFICIENCY. DOI: 2004. DOR: PLANNED AS SOON AS PATIENT SPECIFIC IMPLANT WILL BE MANUFACTURED BY DEPUY IN SPRING 2024. LEFT HIP.

  Patient problems: Insufficient Information

  MAUDE report 18649905 ↗
• InjuryDec 13, 2022Naturally Worn; Naturally Worn

  SURGEON IS ORDERING A PATIENT SPECIFIC PE INLAY FOR A PLANNED REVISION BECAUSE OF NORMAL AND EXPECTED PE-WEAR LEFT SIDE. DOI: (B)(6) 2003. DOR: PLANNED AS SOON AS PATIENT SPECIFIC IMPLANT WILL BE MANUFACTURED BY DEPUY IN 2023. THERE HAS BEEN NO ALLEGATION OF ANY PRODUCT DEFICIENCY.

  Patient problems: Insufficient Information

  MAUDE report 15968525 ↗